{"version":"1.0","provider_name":"Thema - Medical Regulatory Consultancy","provider_url":"https:\/\/www.thema-med.com\/es\/","author_name":"ufficiomarketing","author_url":"https:\/\/www.thema-med.com\/es\/author\/ufficiomarketing\/","title":"Reino Unido: Directrices de vigilancia poscomercializaci\u00f3n - Thema - Medical Regulatory Consultancy","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7C2Ji6vEuT\"><a href=\"https:\/\/www.thema-med.com\/es\/2025\/01\/22\/reino-unido-directrices-de-vigilancia-poscomercializacion\/\">Reino Unido: Directrices de vigilancia poscomercializaci\u00f3n<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.thema-med.com\/es\/2025\/01\/22\/reino-unido-directrices-de-vigilancia-poscomercializacion\/embed\/#?secret=7C2Ji6vEuT\" width=\"600\" height=\"338\" title=\"\u00abReino Unido: Directrices de vigilancia poscomercializaci\u00f3n\u00bb \u2014 Thema - Medical Regulatory Consultancy\" data-secret=\"7C2Ji6vEuT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"http:\/\/www.thema-med.com\/wp-content\/uploads\/2025\/01\/1Regno-Unito.png","thumbnail_width":1920,"thumbnail_height":1080,"description":"La MHRA public\u00f3 una directriz para aclarar las disposiciones de la reciente enmienda al Reglamento de Productos Sanitarios public\u00f3 una directriz para aclarar las disposiciones de la reciente enmienda al Reglamento de Productos Sanitarios"}